22 May 2025
Celebrating 20 years of EuroIntervention!
According to Editor-in-Chief, Davide Capodanno, EuroIntervention marks this milestone by continuing its upward trajectory, blending cutting-edge and traditional elements to bring the latest data to its readers faster than ever before.
As we enter our twentieth year, the first point to note is that the journal is in very good shape. Our journal metrics and Impact Factor place EuroIntervention in the first quartile among cardiovascular journals and everything is increasing – visits, views and downloads. In 2024, there was an upturn of 9% in the number of submissions after a preceding period of relative stability. We have also seen a dramatic rise in interest on social media, including a 52% increase on LinkedIn, with 10,000 followers, and a 44% increase on Instagram, with over 3,000 followers. The success may be attributed to developments over the five years since the new editorial board was introduced, and it is nice to see the fruits of our labour being realised.
We are very happy to report that providing two-weekly as opposed to monthly issue frequency appears to have the approval of the readership and is a fantastic way to get new and exciting data out more quickly. This, together with the considerable shortening of the time between acceptance and publication, is achieving our aim of making EuroIntervention the go-to news outlet. We hope people now see the journal as a source of up-to-the-minute information, with articles that tell insightful stories.
The new website, launched in 2024, provides a clean, modern layout and the integral AI assistant, Cory, has been really well received by readers. Each issue now has a clearly defined format with a consistent flow of varied article types. The first part features the Introduction and papers discussing cutting-edge topics, along with the Viewpoints and the ever-popular Debates. The State-of-the-Art and Expert Reviews provide an insight into scientific and technical developments, respectively. And alongside Original Research, short-form Research Correspondence articles, Clinical Research and Letter to the Editor, we are publishing a growing number of clinical trial design papers.
We have worked hard to improve the author experience, streamlining and simplifying the submission process, for example by removing the need for complex formatting at the initial stage. And we are rewarding submitters by constantly exploring new ways to amplify their paper’s reach. In addition to maximising our social media presence, we have created newsletters, such as the EuroIntervention Digest, featuring selected articles around one topic, and the Editor’s Choice, in which we select some of the most promising and impactful papers.
Join the celebrations at EuroPCR 2025 and take part in our collaborative session, which highlights that published papers, far from being just dry academic research, actually impact patient management. In this interactive format, speakers describe how they found solutions to difficult clinical cases by using information from EuroIntervention. The journal also published a number of articles simultaneously during EuroPCR 2025 including two consensus papers focusing on treatment strategies in women with cardiovascular disease – one on cardiogenic shock and another on antithrombotic therapy – together with the 4D-ACS major late-breaking trial.
This is a momentous year for EuroIntervention; two decades of success is a considerable achievement for any journal. As we celebrate throughout 2025 – with elements including a special cover and an exciting new series of podcasts – we also look ahead to the next 20 years and to developing the journal so it keeps pace with the evolving needs of the interventional cardiology community.
